NEW YORK (360Dx) – Numares confirmed on Wednesday that its test for diagnosing kidney rejection has received CE-IVD marking. The firm has launched it in Europe.

Called renalTX-Score, the test is the first to be available worldwide that evaluates a metabolic biomarker network, rather than single biomarkers or tissue biopsy for diagnosing acute rejection following a kidney transplant, Numares said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.